| 标题 |
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:J. Abramson; S. Geyer; Sharmila Giri; L. Pederson; A. Hudson; et al 出版日期:2026-09-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)